Target intelligence / Profile preview

NAD(P)HX epimerase pseudogene 1 (NAXEP1)

Target
NAXEP1
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

NAD(P)HX epimerase pseudogene 1 (NAXEP1) is a non-coding segment of DNA that resembles the NAXE gene but contains mutations that prevent it from producing a functional enzyme. Pseudogenes like NAXEP1 may arise by gene duplication or retrotransposition, and typically have no protein-coding function. Some pseudogenes have regulatory activity at the RNA level, such as acting as miRNA decoys or influencing gene expression, but there is no evidence that NAXEP1 has such a role. NAXEP1 is not considered a therapeutic target and is primarily relevant for genomic annotation and understanding gene evolution[3][5][13][15].\n\nKey points:\n- NAXEP1 is not a functional enzyme, receptor, or therapeutic target, but a genetic relic of its protein-coding ancestor NAXE.\n- Pseudogenes like NAXEP1 are generally classified under \"Other\" molecular classifications, since they do not encode active biological functions or drug targets[3][5][13].\n- There is no evidence or published information of NAXEP1 being used as a biomarker, disease gene, or pharmacological target.\n- No drugs, mechanisms of action, or safety concerns directly relate to NAXEP1.\n\nIf you believe NAXEP1 may play a biological or regulatory role in specific contexts (e.g., through RNA), or you require variant-specific annotation, these areas are generally unresolved for this pseudogene and lack direct literature support.

Other names
NAXE pseudogene 1NAD(P)HX epimerase pseudogeneapolipoprotein A-I binding protein pseudogeneNAXEP1
02

Biological functions

Other (pseudogenes can regulate gene expression via RNA-based mechanisms—rare for pseudogenes and not specifically described for NAXEP1[3][13][15])
03

Disease associations

Other (typically, most pseudogenes lack direct disease associations unless functioning as RNA regulators; no disease role described for NAXEP1)

Beyond the preview

Go deeper on NAD(P)HX epimerase pseudogene 1 (NAXEP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD(P)HX epimerase pseudogene 1 (NAXEP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call